A

AbCellera Biologics

ABCL

3.06000
USD
-0.19
(-5.85%)
Market Open
Volume
18,891
EPS
0
Div Yield
0
P/E
-5
Market Cap
828,010,145
Related Instruments
A
AMTI
0
(0%)
0.000000 USD
A
ASAN
-0.500
(-3.44%)
14.050 USD
B
BAND
-6.830
(-29.98%)
15.950 USD
C
CDLX
-0.33000
(-3.99%)
7.94000 USD
I
INST
0.000
(0.00%)
23.360 USD
U
UPST
-2.560
(-9.16%)
25.400 USD
News

Title: AbCellera Biologics

Sector: Healthcare
Industry: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.